论文部分内容阅读
为探讨准分子激光屈光性角膜切削术（ＰＲＫ）术后分别使用０．１％地塞米松、爱氟龙及拂炎三种不同的皮质类固醇激素性眼液１～３个月对眼压的影响，作者总结和分析了共５４６只眼的随访资料。结果显示上述三种眼液引起眼压升高的比例不同，地塞米松组为３６％，爱氟龙组为１２．４％，拂炎组３１．９％。眼压升高最早可发生在用药后２周，但大多数在１月左右。有１１例双眼眼压升高的病例出现自觉症状，表现为视力下降、眼球胀痛、虹视等。其它病例没有任何自觉症状。在停用皮质类固醇激素和抗青光眼治疗３～７天后，眼压得到控制。作者认为，在ＰＲＫ术后使用皮质类固醇激素眼液２周以后就应进行眼科检查，以防治皮质类固醇激素性高眼压。
In order to investigate the effect of intraocular pressure (IOP) on intraocular pressure (IOP) of 1 ~ 3 months after excimer laser refractive keratectomy (PRK) and 0.1% dexamethasone, The author summarizes and analyzes a total of 546 eyes of follow-up information. The results showed that the three kinds of eye drops caused by different rates of intraocular pressure, dexamethasone group was 36%, 12.4% fluorine dragon group, 31.9% Fu Yan group. Intraocular pressure can occur as early as 2 weeks after treatment, but mostly in January or so. Eleven cases of elevated intraocular pressure in patients with symptoms, manifested as vision loss, eye pain, Hong Hong and so on. Other cases do not have any symptoms. Intraocular pressure was controlled after 3 to 7 days of corticosteroid and anti-glaucoma treatment. The authors believe that ophthalmic examination should be carried out after 2 weeks of PRK postoperative corticosteroid eye drops to prevent and treat corticosteroid-induced ocular hypertension.